Dorna Therapeutics
Waltham, US · Founded 2018 · Delaware corporation
Founders & leadership
MJ
Mousa JafariNamed on SEC filing
JA
John Alfons TabaczynskiNamed on SEC filing
JJ
John J. QuinnNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$300K disclosed across 1 round · 2018
▶$300KraisedJul 2018 · 5 investors · BiotechnologyRule 506(b)
▶$300KraisedJul 2018 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mousa JafariExecutive Officer, Director, Promoter
- John Alfons TabaczynskiDirector, Promoter
- John J. QuinnDirector
- Offering amount
- $300K
- Amount sold
- $300K
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Dorna Therapeutics raised?
- Dorna Therapeutics has disclosed $300K raised across 1 round.
- Where is Dorna Therapeutics headquartered?
- Dorna Therapeutics is headquartered in Waltham, US.